These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38905524)

  • 1. Lotilaner (Xdemvy) for Demodex blepharitis.
    Med Lett Drugs Ther; 2024 Jun; 66(1705):99-100. PubMed ID: 38905524
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and Safety of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Meta-Analysis of Randomized Controlled Trials.
    Muhammad Muneeb Akhtar S; Fareed A; Sohaib Asghar M; Mumtaz M; Kaur S
    Cont Lens Anterior Eye; 2024 Jun; 47(3):102148. PubMed ID: 38514290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Lotilaner Ophthalmic Solution (0.25%) for the Treatment of Demodex Blepharitis: A GRADE Assessed Systematic Review and Meta-Analysis of Observational & Experimental Studies.
    Talha M; Haris Ali M; Fatima E; Nadeem A; Ahmed A; Nashwan AJ
    Am J Ophthalmol; 2024 Aug; 264():8-16. PubMed ID: 38513948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xdemvy
    Gupta AK; Mann A; Vincent K; Abramovits W
    Skinmed; 2024; 22(1):61-66. PubMed ID: 38494618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2).
    Gaddie IB; Donnenfeld ED; Karpecki P; Vollmer P; Berdy GJ; Peterson JD; Simmons B; Edell ARP; Whitson WE; Ciolino JB; Baba SN; Holdbrook M; Trevejo J; Meyer J; Yeu E;
    Ophthalmology; 2023 Oct; 130(10):1015-1023. PubMed ID: 37285925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for demodex blepharitis: patient choice and efficacy.
    Hirsch-Hoffmann S; Kaufmann C; Bänninger PB; Thiel MA
    Klin Monbl Augenheilkd; 2015 Apr; 232(4):384-7. PubMed ID: 25902082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study.
    Sadri E; Paauw JD; Ciolino JB; Nijm L; Simmons B; Meyer J; Gaddie IB; Berdy GJ; Holdbrook M; Baba SN; Jalalat P; Yeu E
    Cornea; 2024 Nov; 43(11):1368-1374. PubMed ID: 38334465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collarette Elimination and
    Gonzalez-Salinas R; Yeu E; Holdbrook M; Baba SN; Ceballos JC; Massaro-Corredor M; Corredor-Ortega C; Ramos-Betancourt N; Quiroz-Mercado H
    J Ocul Pharmacol Ther; 2021 Oct; 37(8):479-484. PubMed ID: 34415795
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: A randomized, controlled, double-masked clinical trial.
    Gonzalez-Salinas R; Karpecki P; Yeu E; Holdbrook M; Baba SN; Ceballos JC; Massaro-Corredor M; Corredor-Ortega C; Ramos-Betancourt N; Quiroz-Mercado H
    Cont Lens Anterior Eye; 2022 Aug; 45(4):101492. PubMed ID: 34332895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of
    Yeu E; Holdbrook M; Baba SN; Ceballos JC; Massaro-Corredor M; Corredor-Ortega C; Ramos-Betancourt N; Quiroz-Mercado H; Gonzalez-Salinas R
    Ocul Immunol Inflamm; 2023 Oct; 31(8):1653-1661. PubMed ID: 35914297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary perspectives in
    Page MR
    J Manag Care Spec Pharm; 2024 Oct; 30(10-a Suppl):S1-S8. PubMed ID: 39222399
    [No Abstract]   [Full Text] [Related]  

  • 12. Demodex blepharitis mimicking eyelid sebaceous gland carcinoma.
    Galea M; Sharma R; Srinivasan S; Roberts F
    Clin Exp Ophthalmol; 2014 Mar; 42(2):208-10. PubMed ID: 23565576
    [No Abstract]   [Full Text] [Related]  

  • 13. [Demodex folliculorum a hidden cause of blepharitis].
    Gunnarsdottir S; Kristmundsson A; Freeman MA; Bjornsson OM; Zoega GM
    Laeknabladid; 2016 May; 102(5):231-5. PubMed ID: 27197131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical ivermectin-metronidazole gel therapy in the treatment of blepharitis caused by Demodex spp.: A randomized clinical trial.
    Ávila MY; Martínez-Pulgarín DF; Rizo Madrid C
    Cont Lens Anterior Eye; 2021 Jun; 44(3):101326. PubMed ID: 32461053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Demodex as an etiological factor in chronic blepharitis].
    Czepita D; Kuźna-Grygiel W; Kosik-Bogacka D
    Klin Oczna; 2005; 107(10-12):722-4. PubMed ID: 16619830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permethrin Cream for the Treatment of Demodex Blepharitis.
    Hecht I; Melzer-Golik A; Sadi Szyper N; Kaiserman I
    Cornea; 2019 Dec; 38(12):1513-1518. PubMed ID: 31169611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demodex folliculorum and Demodex brevis as a cause of chronic marginal blepharitis.
    Czepita D; Kuźna-Grygiel W; Czepita M; Grobelny A
    Ann Acad Med Stetin; 2007; 53(1):63-7; discussion 67. PubMed ID: 18561612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Resistance to routine ophthalmological treatments in a patient with chronic blepharitis].
    Franco-Álvarez de Luna F; Santos Rosa C; Fernández-Villalón JÁ
    Enferm Infecc Microbiol Clin; 2014 Feb; 32(2):127-9. PubMed ID: 23948950
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of Topical Ivermectin 1% in the Treatment of Demodex Blepharitis.
    Choi Y; Eom Y; Yoon EG; Song JS; Kim IH; Kim HM
    Cornea; 2022 Apr; 41(4):427-434. PubMed ID: 34173370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical treatment of ocular Demodex folliculorum by systemic ivermectin.
    Holzchuh FG; Hida RY; Moscovici BK; Villa Albers MB; Santo RM; Kara-José N; Holzchuh R
    Am J Ophthalmol; 2011 Jun; 151(6):1030-1034.e1. PubMed ID: 21334593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.